These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 11689075

  • 1. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M, Boissard C, Patiny L, Chung NN, Lemieux C, Mutter M, Schiller PW.
    J Med Chem; 2001 Nov 08; 44(23):3896-903. PubMed ID: 11689075
    [Abstract] [Full Text] [Related]

  • 2. The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.
    Mollica A, Pinnen F, Stefanucci A, Feliciani F, Campestre C, Mannina L, Sobolev AP, Lucente G, Davis P, Lai J, Ma SW, Porreca F, Hruby VJ.
    J Med Chem; 2012 Apr 12; 55(7):3027-35. PubMed ID: 22394120
    [Abstract] [Full Text] [Related]

  • 3. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG, Verheyden PM, Tourwe D, Van Binst G, Davis P, Burks TF.
    Biopolymers; 1992 Aug 12; 32(8):957-69. PubMed ID: 1330047
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues: part 2.
    Mollica A, Pinnen F, Stefanucci A, Mannina L, Sobolev AP, Lucente G, Davis P, Lai J, Ma SW, Porreca F, Hruby VJ.
    J Med Chem; 2012 Oct 11; 55(19):8477-82. PubMed ID: 22966938
    [Abstract] [Full Text] [Related]

  • 6. Morphiceptin analogues containing a dipeptide mimetic structure: an investigation on the bioactive topology at the mu-receptor.
    Grieco P, Giusti L, Carotenuto A, Campiglia P, Calderone V, Lama T, Gomez-Monterrey I, Tartaro G, Mazzoni MR, Novellino E.
    J Med Chem; 2005 May 05; 48(9):3153-63. PubMed ID: 15857121
    [Abstract] [Full Text] [Related]

  • 7. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R, Vogel D, Mrestani-Klaus C, Brandt W, Neubert K, Chung NN, Lemieux C, Schiller PW.
    J Med Chem; 1994 Apr 15; 37(8):1136-44. PubMed ID: 8164255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW, Nguyen TM, Lemieux C, Maziak LA.
    J Med Chem; 1985 Dec 15; 28(12):1766-71. PubMed ID: 2999401
    [Abstract] [Full Text] [Related]

  • 10. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW, Berezowska I, Nguyen TM, Schmidt R, Lemieux C, Chung NN, Falcone-Hindley ML, Yao W, Liu J, Iwama S, Smith AB, Hirschmann R.
    J Med Chem; 2000 Feb 24; 43(4):551-9. PubMed ID: 10691681
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Lomize AL, Wang C, Kroona H, Heyl DL, Sobczyk-Kojiro K, Ma W, Mousigian C, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4371-83. PubMed ID: 7996549
    [Abstract] [Full Text] [Related]

  • 13. Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2.
    Li T, Fujita Y, Tsuda Y, Miyazaki A, Ambo A, Sasaki Y, Jinsmaa Y, Bryant SD, Lazarus LH, Okada Y.
    J Med Chem; 2005 Jan 27; 48(2):586-92. PubMed ID: 15658871
    [Abstract] [Full Text] [Related]

  • 14. Topochemical analysis of morphiceptin and dermorphin bioactivities.
    Yamazaki T, Ro S, Goodman M.
    Biochem Biophys Res Commun; 1991 Dec 16; 181(2):664-70. PubMed ID: 1661586
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.
    J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975
    [Abstract] [Full Text] [Related]

  • 19. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
    Chang KJ, Wei ET, Killian A, Chang JK.
    J Pharmacol Exp Ther; 1983 Nov 16; 227(2):403-8. PubMed ID: 6313901
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.